Lipid and Arteriosclerosis Research Unit (URLA) and Vascular Medicine and Metabolism Unit (UVASMET)

METABOLIC AND NUTRITION DISEASES
OBJECTIUS

The Lipid and Arteriosclerosis Research Unit was set up in 1985. It employs 18 people (5 UVASMET clinicians). The aim of the group is care and teaching and research activities for lipid metabolism disorders. It is a research group consolidated by the Generalitat de Catalunya, part of the CIBERDEM, the IRB CatSud and the URV. The main lines of research are: Family Hypercholesterolemia; molecular basis of atherogenic dyslipidemia; genetics and epigenetics of lipid disorders.

RESPONSABLES
  • Dr. Josep Ribalta Vives

  • Dra. Daiana Ibarretxe Guerediaga

  • Presentation
  • Research lines
  • Transfer
  • Group members
  • Publications
  • Projects
  • Contact

The Unit of Vascular Medicine and Metabolism (UVASMET) aims at the diagnosis and treatment of severe alterations in lipid metabolism and hypertension as preventive measures of their pathological consequences, primarily cardiovascular diseases, which remain the first cause of mortality in our country, but also pancreatic, liver, kidney diseases, associated with alterations in lipid metabolism.

What are we experts in and in what areas can we collaborate?

  • Clinical trials in patients with dyslipidemia, cardiovascular risk and others.
  • Advanced studies of lipid metabolism, including 1H-MRI of lipoproteins (Liposcale- www.biosferteslab.com)
  • Isolation of lipoproteins by ultracentrifugation.
  • Biomarkers of metabolic and inflammatory diseases.
  • Genetic and epigenetic studies
  • MiRNA studies
  • Basic laboratory techniques.
  • Cell cultures
  • Molecule biology techniques

The research is organized in a coordinated way between both Units: URLA-UVASMET
Director: Lluís Masana
URLA Co-Director: Josep Ribalta

The URLA search is organized along the following lines, under the responsibility of a principal investigator (IP):

  • Family Hypercholesterolemia.
    Responsible: Lluís Masana and Núria Plana.
  • Lipoprotein metabolism, arteriosclerosis, diabetes.
    Responsible: Lluís Masana and Josefa Girona.
  • Diabetic cardiomyopathy
    Responsible: Ricardo Rodríguez
  • Extracellular vesicles and cardiovascular and metabolic diseases
    Responsible: Neus Martínez-Micaelo
  • Atherogenic characteristics of lipoproteins
    Responsible: Josep Ribalta
  • Genetics and epigenetics of dyslipidemias and vascular risk
    Responsible: Montse Guardiola
  • Dyslipidemia, vascular wall and rheumatological diseases
    Responsible: Joan Carles Vallvé
  • Lipid metabolism and cancer (collaboration with Oncology)
    Responsible: Sandra Guaita (Oncology Research Group)

  • Inventors/es (per ordre de signatura): Mallol Parera, Roger; Amigó Grau, Núria; Correig Blanchar, Xavier; Masana Marín, Lluís; Rodríguez Martínez, Miguel Ángel; Heras Ibáñez, Mercedes; Plana Gil, Núria.

    Títol: Methods for determining the lipid distribution between the core and the shell of a lipoprotein particle.

    Núm. de sol·licitud: EP13382477.1 País de prioritat: EPO Data de prioritat: 27/11/2013

    Entitat titular: Universitat Rovira i Virgili (URV) i Fundació Institut d’Investigació Sanitària Pere Virgili (IISPV).

    Empreses que l’exploten: BIOSFER TESLAB, SL

  • Inventors/es (per ordre de signatura): Mallol Parera, Roger; Amigó Grau, Núria; Correig Blanchar, Xavier; Masana Marín, Lluís; Rodríguez Martínez, Miguel Ángel; Heras Ibáñez, Mercedes; Plana Gil, Núria;  Ribalta Vives, Josep.

    Títol: Method for the characterization of lipoproteins.

    Núm. de sol·licitud: EP12382478.9 País de prioritat: EPO Data de prioritat: 27/11/2013

    Entitat titular: Universitat Rovira i Virgili (URV) i Fundació Institut d’Investigació Sanitària Pere Virgili (IISPV)

    Empreses que l’exploten: BIOSFER TESLAB, SL

  • CONSTITUCIÓ SPIN-OFF

    Participació com a soci de l’EBT Spin-off BIOSFER TESLAB, SL, constituïda davant notari el 20/12/2013 amb número de protocol: 2105. Societat mercantil participada per les institucions: Universitat Rovira i Virgili i la Fundació Institut d’Investigació Sanitària Pere Virgili.

    Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by (1)H-NMR. A real-world observational study (IPE-NMR).

    Amigó N, Dalli-Peydró E, Díaz-Díaz JL, Oterino A, Cabau L, Ballestín-Ballestín J, Garcia-Moll X, Masana L. 01/11/2026

    Myeloid-Derived Suppressor Cells (MDSCs) in Cardiovascular Risk of Obesity-Associated Diabetes

    Flores-Campos, R, Hontecillas-Prieto, L, García-Domínguez, DJ, Fernández-Suárez, A, Egusquiza-Lasuen, I, Pérez, A, Ribalta, J, Pedro-Botet, J, Sánchez-Margalet, V. 03/09/2026

    Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit.

    Di Giacomo Barbagallo F, González-Lleó A, Amigo N, Bosco G, Ibarretxe D, Piro S, Scicali R, Masana L. 01/09/2026

    CHANGES IN LIPOPROTEIN LPS AFTER LIFESTYLE INTERVENTION IN SUBJECTS WITH METABOLIC SYNDROME

    Banús, H, Rehues, P, Atzeni, A, Salas-Salvadó, J, Ribalta, J, Guardiola, M. 01/09/2026

    Lipopotrein(a): from the complex metabolism to the optimal lowering drug.

    Di Giacomo Barbagallo F, Berteotti M, Bosco G, Cosco L, Di Pino A, Alfano F, Piro S, Scicali R, Masana L, Marcucci R. 10/08/2026

    Palmitic and oleic acids in type 2 diabetes mellitus.

    Palomer X, Rodríguez-Calvo R, Tajes M, Wahli W, Vázquez-Carrera M. 01/08/2026

    Admission lipid profile and outcomes in sepsis requiring early invasive source control.

    Piris JAB, Pérez SP, Quintana PFC, Benedicto PMG, Barrios XG, Parra LC, Segarra XN, Anglès CR, Perapoch IV, Salomó AC. 15/07/2026

    Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

    Wiegman A, Bourbon M, Freiberger T, Gidding SS, Greber-Platzer S, Groselj U, Holven KB, Hudgins LC, Humphries SE, Hutten BA, Ibarretxe D, Pederiva C, Peretti N, Raal FJ, Ramaswami U, Sanin V, Santos RD, Steinhagen-Thiessen E, Watts GF, Perkins R, Benn M, Binder CJ, Romeo S, Roeters van Lennep JE. 07/07/2026

    Composition and Characterization of the Different Lipoproteins in Overweight/Obese Children vs. Normal-Weight Children.

    Cuenca-Alcocel J, Villalba-Heredia L, Ibarretxe D, Casajús JA, Arbonés-Mainar JM, Calmarza P. 23/06/2026

    Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease.

    Nordestgaard LT, Magni P, Sopic M, Chemaly M, Matic L, Dalila N, Trindade F, Wolford BN, Rodriguez-Hernandez Z, Amigó N, Catapano AL, Masana L, Devaux Y. 01/04/2026

    Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition.

    Pavón R, Parra S, Rubio FJ, Feliu M, Ríos M, Iftimie S, Rovira C, Amigó N, Cabau L, Martínez-Micaelo N, Castro A. 03/03/2026

    SEA 2026 Standards for Global Control of Vascular Risk.

    Mostaza JM, Pintó X, Armario P, Guijarro C, Masana L, Real JT, Arrobas-Velilla T, Baeza-Trinidad R, Calmarza P, Cebollada J, Civera-Andrés M, Cuende Melero JI, Díaz-Díaz JL, Fernández Pardo J, Jericó C, Lahoz C, López-Melgar B, López-Miranda J, Martínez-Hervás S, Muñiz-Grijalvo O, Páramo JA, Pascual V, Pedro-Botet J, Pérez-Martínez P, Puzo J, Tamarit JJ. 01/03/2026

    Inclisiran for children: is it worth it?

    Masana L, Ibarretxe D. 01/03/2026

    Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease

    García-Mateo, S, Martínez-Domínguez, SJ, Gargallo-Puyuelo, CJ, Gallego, B, Alfambra, E, Aso, M, Martínez-Micaelo, N, Amigó, N, Ribalta, J, Guardiola, M, del Rio-Nechaevsky, M, Martínez-García, J, Baptista, PM, Gomollón, F. 01/01/2026

    Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease

    Julve, J, Rodriguez-Calvo, R, Perret, B, Martinez, LO, Mauricio, D. 11/12/2025

    A Robust Multivariate Approach Unveils a 1H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study

    Rehues, P, Guardiola, M, Amigo, N, Rojo-Martinez, G, Mallol-Parera, R, Ribalta, J. 05/12/2025

    Widespread lipoprotein alterations in a REDUCE-IT like population: The icosapent ethyl (IPE)-NMR avatar study

    Masana, L, Torné, P, Garcia-Moll, X, Dalli, E, Amigo, N. 01/11/2025

    Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach

    Zamora, A, Masana, L, Civeira, F, Ibarretxe, D, Fanlo-Maresma, M, Vila, A, Tembra, MS, Marco-Benedí, V, Alvarez-Sala-Walther, LA, Camacho-Ruiz, M. 01/11/2025

    The multiomics blueprint of the individual with the most extreme lifespan

    Santos-Pujol, E, Noguera-Castells, A, Casado-Pelaez, M, García-Prieto, CA, Vasallo, C, Campillo-Marcos, I, Quero-Dotor, C, Crespo-García, E, Bueno-Costa, A, Setién, F, Ferrer, G, Davalos, V, Mereu, E, Pluvinet, R, Arribas, C, de la Torre, C, Villavicencio, F, Sumoy, L, Granada, I, Coles, NS, Acha, P, Solé, F, Mallo, M, Mata, C, Peregrina, S, Gabaldón, T, Llirós, M, Pujolassos, M, Carreras-Torres, R, Lluansí, A, García-Gil, LJ, Aldeguer, X, Samino, S, Torné, P, Ribalta, J, Guardiola, M, Amigó, N, Yanes, O, Martínez, P, Sánchez-Vásquez, R, Blasco, MA, Oviedo, J, Lemos, B, Rius-Bonet, J, Torrubiano, M, Massip-Salcedo, M, Khidir, KA, Cao, TH, Quinn, PA, Jones, DJL, Macip, S, Brigos-Barril, E, Moldes, M, Barteri, F, Muntané, G, Laayouni, H, Navarro, A, Esteller, M. 21/10/2025

    Atherosclerotic cardiovascular disease and mortality in a cohort of patients with rheumatoid arthritis: a prospective study investigating microRNAs as predictors of atherosclerosis and mortality

    Llop, D, Paredes, S, Ibarretxe, D, Rosales, R, Masana, L, Ribalta, J, Vallvé, JC. 08/10/2025

    Sudden death in a homozygous familial hypercholesterolemic child with noncompaction cardiomyopathy. Just a coincidence?

    Ibarretxe-Guerediaga, D, Marimon, C, Feliu, A, Rodríguez-Borjabad, C, Plana, N, Masana, L. 01/10/2025

    Multiomics in atherosclerotic cardiovascular disease

    Nordestgaard, LT, Wolford, BN, de Gonzalo-Calvo, D, Sopic, M, Devaux, Y, Matic, L, Wettinger, SB, Schmid, JA, Amigó, N, Masana, L, Catapano, AL, Kardassis, D, Magni, P. 01/09/2025

    Triglycerides as Determinants of Global Lipoprotein Derangement: Implications for Cardiovascular Prevention

    Amigó, N, Torne, P, Nordestgaard, LT, Di Giacomo-Barbagallo, F, Merino, C, Magni, P, González-Lleó, A, Andreychuk, N, Catapano, AL, Masana, L, Ibarretxe, D. 26/08/2025

    Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study

    Tajes, M, Ras-Jimenez, MD, Girona, J, Ramos-Polo, R, Guardiola, M, Garcia-Pinilla, JM, Ribalta, J, Cobo-Marcos, M, Masana, L, de Juan-Bagudá, J, Fonseca, C, Enjuanes, C, Vázquez-Carrera, M, Comin-Colet, J, Rodriguez-Calvo, R. 26/08/2025

    Age-related and sex-related increase in Lp(a). Role of triglycerides

    Benedi, VM, Laclaustra, M, Bea, AM, Tembra, MS, Plana, N, Pinto, X, Vila, A, Civeira, F. 01/08/2025

    Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis

    Narváez, J, Aguilar-Coll, M, Roig-Kim, M, Palacios-Olid, J, Maymó-Paituvi, P, de Daniel-Bisbe, L, Llop, D. 30/05/2025

    Plasma expression of a microRNA panel is differentially associated with 1H-NMR lipoprotein profile in rheumatoid arthritis patients

    Llop, D, Paredes, S, Rosales, R, Ribalta, J, Vallvé, JC. 01/05/2025

    New Cardiovascular Risk Biomarkers in Rheumatoid Arthritis: Implications and Clinical Utility-A Narrative Review

    Pamies, A, Vallvé, JC, Paredes, S. 03/04/2025

    Advancing atherosclerosis research: The Power of lipid imaging with MALDI-MSI

    Bookmeyer, CHM, Correig, FX, Masana, L, Magni, P, Yanes, O, Vinaixa, M. 01/04/2025

    Familial Combined Hyperlipidemia: Myth or Reality?

    Brouwers, MCGJ, Klop, B, Ribalta, J, Cabezas, MC. 01/04/2025

    Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

    Barbagallo, FD, Bosco, G, Di Marco, M, Scilletta, S, Miano, N, Musmeci, M, Martedi, M, González-Lleó, AM, Ibarretxe, D, De Francesco, EM, Malaguarnera, R, Di Pino, A, Masana, L, Purrello, F, Piro, S, Scicali, R. 20/03/2025

    GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease

    Girona, J, Guardiola, M, Barroso, E, García-Altares, M, Ibarretxe, D, Plana, N, Ribalta, J, Amigó, N, Correig, X, Vázquez-Carrera, M, Masana, L, Rodríguez-Calvo, R. 01/03/2025

    Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study

    Amigó, N, Castelblanco, E, Julve, J, Martínez-Micaelo, N, Alonso, N, Hernández, M, Ribalta, J, Guardiola, M, Torán-Monserrat, P, Lopez-Lifante, V, Herrero-Alonso, C, Arteaga, I, Ortega, E, Franch-Nadal, J, Mauricio, D. 21/02/2025

    Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis.

    Bosco G, Di Giacomo Barbagallo F, Di Marco M, Scilletta S, Miano N, Capuccio S, Musmeci M, Di Mauro S, Filippello A, Scamporrino A, Di Pino A, Masana L, Purrello F, Piro S, Scicali R. 01/02/2025

    Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society

    Pedro-Botet, J, Arrieta, F, Botana, M, Gimeno-Orna, JA, Martinez-Montoro, JI, de Victoria, EOM, Ribalta, J, Sánchez-Margalet, V, Pérez-Pérez, A. 01/02/2025

    Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation

    Llop, D, Rehues, P, Paredes, S, Guardiola, M, Girona, J, Rosales, R, Esteban, Y, Masana, L, Ibarretxe, D, Vallvé, JC, Ribalta, J. 08/01/2025

    The CNIC polypill (Acetylsalicylic acid plus Atorvastatin plus Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approaches

    González-Juanatey, JR, Masana, L, Dalmau, R, Cordero, A. 01/01/2025

    Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study.

    Mostaza JM, Lahoz C, de Yébenes Castro MG, Rubio Campal JM, Velásquez E, Ibarra Gutiérrez A, Díaz JF, Plana N, Rodríguez-Mañero M, de Dios García-Díaz J, Martínez Debén F, Pavón de Paz I, Catapano AL, Díaz Moya G, Ray KK. 01/10/2025

    Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

    Uribe-Herranz, M, Oliver-Caldés, A, Martínez-Micaelo, N, Español-Rego, M, Val-Casals, M, Martínez-Soler, R, Rubio-Garcia, E, Brunello, V, Mihelic, EZ, Klein-González, N, Benítez-Ribas, D, Amigó, N, Vergara, A, Ortiz-Maldonado, V, Rodríguez-Lobato, LG, Delgado, J, de Landazuri, IO, González-Calle, V, Cabañas, V, Martin-Antonio, B, Pérez-Amill, L, Reguera-Ortega, JL, Rodríguez-Otero, P, Paiva, B, Martínez-López, J, Mateos, MV, Pascal, M, Urbano-Ispizua, A, González-Navarro, EA, de Larrea, CF, Juan, ME. 03/09/2025

    apoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles

    Rehues, P, Girona, J, Guardiola, M, Ozcariz, E, Amigó, N, Rosales, R, Esteban, Y, Banús, H, Alsina, GG, González-Lleó, A, Rojo-Martínez, G, Ribalta, J. 01/08/2025

    Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study.

    Martínez-Falguera D, Aranyó J, Ferrer-Curriu G, Teis A, Revuelta-Lopez E, Diaz-Güemes I, Monguió-Tortajada M, Fadeuilhe E, Rodríguez-Leor O, Poblador F, Montejo B, Roura S, Villuendas R, Sarrias A, Bazan V, Jorge E, Delgado V, Jimenez-Trinidad FR, Rigol M, Martinez-Micaelo N, Amigó N, Bayes-Genis A, Bisbal F, Gálvez-Montón C. 03/06/2025

    Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition Medical Life-Trajectories in the Post-2010 Era

    Mulder, JWCM, Reijman, MD, Kusters, DM, Boersma, E, Alnouri, F, Blom, DJ, Catapano, AL, Cuchel, M, Dann, EJ, Freiberger, T, Groselj, U, Harada-Shiba, M, Hovingh, GK, Iatan, I, Ibarretxe, D, Kayikcioglu, M, Kim, NT, Klingel, R, Raal, FJ, Reeskamp, LF, Sadiq, F, Schonck, WAM, Tromp, TR, Truong, TH, Wiegman, A, van Lennep, JER. 20/05/2025

    miR-130a expression is related to aortic dilation in bicuspid aortic valve children

    Antequera-González, B, Collell-Hernández, R, Martínez-Micaelo, N, Marimon-Blanch, C, Carbonell-Prat, B, Escribano, J, Alegret, JM. 26/01/2024

    The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia

    Daiana, I, Didac, L, Celia, RB, Natalia, A, Nuria, P, Roberto, S, Ana, GL, Nuria, A, Josefa, G, Lluis, M. 23/01/2024

    Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy (1H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes

    Nattero-Chávez, L, Insenser, M, Amigó, N, Samino, S, Martínez-Micaelo, N, Avendaño, BD, Tobar, AQ, Escobar-Morreale, HF, Luque-Ramírez, M. 06/01/2024

    Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets.

    Masana L, Díaz Moya G, Pérez de Isla L. 01/01/2024

    Specific Multiomic Profiling in Aortic Stenosis in Bicuspid Aortic Valve Disease.

    Antequera-González B, Martínez-Micaelo N, Sureda-Barbosa C, Galian-Gay L, Siliato-Robles MS, Ligero C, Evangelista A, Alegret JM. 06/02/2024

    Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

    González-Lleó, AM, Sánchez-Hernández, RM, Plana, N, Ibarretxe, D, Rehues, P, Ribalta, J, Llop, D, Wägner, AM, Masana, L, Boronat, M. 03/01/2024

    PPARß/d upregulates the insulin receptor ß subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels

    Wang, JR, Jurado-Aguilar, J, Barroso, E, Rodriguez-Calvo, R, Camins, A, Wahli, W, Palomer, X, Vázquez-Carrera, M. 18/12/2024

    Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society

    Sánchez-Hernández, RM, Ibarretxe, D, Jiménez, FF, Martínez-Hervás, S, Blanco-Echevarria, A, Rodríguez, BC, Rodríguez-Carnero, G, Ordiales, MMM, Pérez, A, González-Bustos, P, Armesto, RA, Sánchez-Sobrino, P, Masana, L, Civeira, F. 05/12/2024

    ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III

    Rehues, P, Girona, J, Guardiola, M, Ozcariz, E, Amigó, N, Rosales, R, Esteban, Y, Banús, H, Gavaldà-Alsina, G, González-Lleó, A, Rojo-Martínez, G, Ribalta, J. 04/12/2024

    Angiopoietin-2, vascular endothelial growth factor family, and heparin binding endothelial growth factor are associated with subclinical atherosclerosis in rheumatoid arthritis

    Pàmies, A, Llop, D, Ibarretxe, D, Rosales, R, Masana, L, Vallvé, JC, Paredes, S. 01/12/2024

    Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field

    Di Giacomo-Barbagallo, F, Andreychuk, N, Scicali, R, Gonzalez-Lleo, A, Piro, S, Masana, L, Ibarretxe, D. 01/12/2024

    New drugs for treating dyslipidemias. From small molecules to small interfering RNAs

    Masana, L, Ibarretxe, D. 01/12/2024

    Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19) results from the efficacy phase of an open-label, multicentre, phase 3 study

    Masana, L, Zambon, A, Schmitt, CP, Taylan, C, Driemeyer, J, Cohen, H, Buonuomo, PS, Alashwal, A, Al-Dubayee, M, Kholaif, N, Diaz-Diaz, JL, Maatouk, F, Martinez-Hervas, S, Mangal, B, Löwe, S, Cunningham, T. 01/12/2024

    Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain

    Giraldo, P, Camprodón, M, Alcolea, PC, Gras-Colomer, E, Ibarretxe, D, Lakhwani, S, Mora, E, Calderón, MPV, Morales-Conejo, M. 15/11/2024

    H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort

    Ozcariz, E, Guardiola, M, Amigó, N, Valdés, S, Oualla-Bachiri, W, Rehues, P, Rojo-Martinez, G, Ribalta, J. 07/11/2024

    Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controls

    Llop, D, Paredes, S, Rosales, R, Amigo, N, Masana, L, Ribalta, J, Vallvé, JC. 02/11/2024

    The GDF15 3' UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis

    Guardiola, M, Girona, J, Barroso, E, García-Altares, M, Ibarretxe, D, Plana, N, Ribalta, J, Correig, X, Vázquez-Carrera, M, Masana, L, Rodríguez-Calvo, R. 01/11/2024

    Serum Levels of Trace Elements (Magnesium, Iron, Zinc, Selenium, and Strontium) are Differentially Associated with Surrogate Markers of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis

    Vera, E, Vallvé, JC, Linares, V, Paredes, S, Ibarretxe, D, Bellés, M. 30/10/2024

    Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg

    González-Juanatey, JR, Cordero, A, Masana, L, Dalmau, R. 01/10/2024

    PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.

    Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. 01/10/2024

    Differential analysis of lipoprotein and glycoprotein profiles in bacterial infections and COVID-19 using proton nuclear magnetic resonance and machine learning

    Iftimie, S, Amigó, N, Martínez-Micaelo, N, López-Azcona, AF, Martínez-Navidad, C, Castañé, H, Jiménez-Franco, A, Ribalta, J, Parra, S, Castro, A, Camps, J, Joven, J. 15/09/2024

    PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

    Marco-Benedí, V, Sánchez-Hernández, RM, Díaz, JL, Jarauta, E, Suárez-Tembra, M, Pintó, X, Morillas, C, Plana, N, Pedro-Botet, J, Civeira, F. 10/09/2024

    Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients

    Pamies, A, Llop, D, Ibarretxe, D, Rosales, R, Girona, J, Masana, L, Vallvé, JC, Paredes, S. 01/09/2024

    Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia

    Saballs, M, Parra, S, Martínez, N, Amigo, N, Cabau, L, Iftimie, S, Pavon, R, Gabaldó, X, Correig, X, Paredes, S, Vallvé, JM, Castro, A. 01/09/2024

    Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    Guardiola, M, Rehues, P, Amigó, N, Arrieta, F, Botana, M, Gimeno-Orna, JA, Girona, J, Martínez-Montoro, JI, Ortega, E, Pérez-Pérez, A, Sánchez-Margalet, V, Pedro-Botet, J, Ribalta, J. 01/08/2024

    HOFH IS A LIFE LIMITING CONDITION: THE LIFE JOURNEY OF DECEASED HOFH PATIENTS IN THE HICC REGISTRY

    Mulder, JWCM, Reijman, MD, Kusters, DM, Boersma, E, Blom, D, Cuchel, M, Dann, EJ, Freiberger, T, Groselj, U, Harada-Shiba, M, Hovingh, G, Ibarretxe, D, Kim, T, Klingel, R, Raal, FJ, Reeskamp, L, Sadiq, F, Schonck, W, Truong, H, Tromp, TR, Wiegman, A, Van Lennep, JR. 01/08/2024

    HIGHER ADHERENCE TO THE MEDITERRANEAN DIET IS ASSOCIATED WITH IMPROVED GLYCEMIC CONTROL AND REDUCED ATHEROGENIC PATTERNS: A POPULATION-BASED STUDY

    Olmastroni, E, Amigo, N, Ribalta, J, Guardiola, M, Rojo, G, Casula, M, Magni, P, Catapano, A. 01/08/2024

    Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice

    Delgado-Lista, J, Mostaza, JM, Arrobas-Velilla, T, Blanco-Vaca, F, Masana, L, Pedro-Botet, J, Perez-Martinez, P, Civeira, F, Cuende-Melero, JI, Gomez-Barrado, JJ, Lahoz, C, Pinto, X, Suarez-Tembra, M, Lopez-Miranda, J, Guijarro, C. 01/07/2024

    Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN

    Reijman, MD, Kusters, DM, Groothoff, JW, Arbeiter, K, Dann, EJ, de Boer, LM, de Ferranti, SD, Gallo, A, Greber-Platzer, S, Hartz, J, Hudgins, LC, Ibarretxe, D, Kayikcioglu, M, Klingel, R, Kolovou, GD, Oh, J, Planken, RN, Stefanutti, C, Taylan, C, Wiegman, A, Schmitt, CP. 01/05/2024

    SEA 2024 Standards for Global Control of Vascular Risk

    Mostaza, JM, Pintó, X, Armario, P, Masana, L, Real, JT, Valdivielso, P, Arrobas-Velilla, T, Baeza-Trinidad, R, Calmarza, P, Cebollada, J, Civera-Andrés, M, Melero, JIC, Díaz-Díaz, JL, Espíldora-Hernández, J, Pardo, JF, Guijarro, C, Jericó, C, Laclaustra, M, Lahoz, C, López-Miranda, J, Martínez-Hervás, S, Muñiz-Grijalvo, O, Páramo, JA, Pascual, V, Pedro-Boteta, J, Pérez-Martínez, P, Puzo, J. 01/05/2024

    Lipidomics Reveals Myocardial Lipid Composition in a Murine Model of Insulin Resistance Induced by a High-Fat Diet

    Girona, J, Soler, O, Samino, S, Junza, A, Martínez-Micaelo, N, García-Altares, M, Ràfols, P, Esteban, Y, Yanes, O, Correig, X, Masana, L, Rodríguez-Calvo, R. 01/03/2024

    The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

    Dalmau, R, Cordero, A, Masana, L, Ruiz, E, Sicras-Mainar, A, González-Juanatey, JR. 01/03/2024

    Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia.

    Ben-Omran T, Masana L, Kolovou G, Ariceta G, Nóvoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Ibarretxe D, Sanchez-Hernández RM, Santos RD. 20/02/2024

    Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes.

    Vilariño-García T, Polonio-González ML, Pérez-Pérez A, Ribalta J, Arrieta F, Aguilar M, Obaya JC, Gimeno-Orna JA, Iglesias P, Navarro J, Durán S, Pedro-Botet J, Sánchez-Margalet V. 16/02/2024

    Association between exposure to air pollution and blood lipids in the general population of Spain

    Valdés, S, Doulatram-Gamgaram, V, Maldonado-Araque, C, Garcia-Escobar, E, Garcia-Serrano, S, Oualla-Bachiri, W, Garcia-Vivanco, M, Garrido, JL, Gil, V, Martin-Llorente, F, Calle-Pascual, A, Castaño, L, Delgado, E, Menéndez, E, Franch-Nadal, J, Gaztambide, S, Girbés, J, Chaves, FJ, Galán-García, JL, Aguilera-Venegas, G, Vallvé, JC, Amigó, N, Guardiola, M, Ribalta, J, Rojo-Martínez, G. 01/02/2024

    A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients

    Llop, D, Ibarretxe, D, Plana, N, Rosales, R, Taverner, D, Masana, L, Vallvé, JC, Paredes, S. 03/04/2023

    MicroRNAs as potential diagnostic biomarkers.

    Llop D. 24/02/2023

    Pregnancy homocysteine and cobalamin status predict childhood metabolic health in the offspring

    Rojas-Gómez, A, Solé-Navais, P, Cavallé-Busquets, P, Ornosa-Martin, G, Grifoll, C, Ramos-Rodriguez, C, Fernandez-Ballart, J, Masana, L, Ballesteros, M, Ueland, PM, Murphy, MM. 01/02/2023

    Glycoprotein Serum Concentrations Assessed By 1H-NMR are Increased in Patients With High Blood Pressure.

    Andreychuk N, Llop D, Moreno-Vedia J, Girona J, Ibarretxe D, Rodríguez-Borjabad C, Plana N, Masana L. 01/02/2023

    Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project.

    Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, Fernández-Galán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, Madinaveitia-Ochoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ, Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E, Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, Arévalo-Vargas I, Andrade-Campos M, Giraldo P. 15/12/2023

    Lipidomics of triglyceride-rich lipoproteins derived from hyperlipidemic patients on inflammation.

    Moreno-Vedia J, Llop D, Rodríguez-Calvo R, Plana N, Amigó N, Rosales R, Esteban Y, Masana L, Ibarretxe D, Girona J. 27/11/2023

    Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study.

    Blanco Echevarría A, García Díaz JD, Caixas A, Plana Gil N, Rico Corral MÁ, Bridges I, Dhalwani N, Gatell Menchen S, Ray KK. 01/11/2023

    Plasma Expression of Carotid Plaque Presence-Related MicroRNAs Is Associated with Inflammation in Patients with Rheumatoid Arthritis

    Llop, D, Paredes, S, Ibarretxe, D, Taverner, D, Plana, N, Rosales, R, Masana, L, Vallvé, JC. 01/10/2023

    Lipoprotein profile assessed by 1H NMR, BMI and blood pressure are associated with vascular alterations in children with familial hypercholesterolaemia

    Llop, D, Feliu, A, Ibarretxe, D, Escribano, J, Plana, N, Borjabad-Rodríguez, C, Masana, L, Vallvé, JC. 01/10/2023

    Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease

    Moreno-Vedia, J, Llop, D, Rodríguez-Calvo, R, Plana, N, Amigó, N, Rosales, R, Esteban, Y, Girona, J, Masana, L, Ibarretxe, D. 14/09/2023

    Associations between blood levels of trace elements and cardiovascular risk factors in patients with rheumatoid arthritis

    Vera, E, Vallvé, JC, Linares, V, Mateu, MB. 01/09/2023

    NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study

    Ozcariz, E, Guardiola, M, Amigó, N, Rojo-Martínez, G, Valdés, S, Rehues, P, Masana, L, Ribalta, J. 01/08/2023

    Lipidomics of triglyceride-rich lipoproteins determines Particle/THP-1 macrophages Interaction and systemic inflammatory profile assessed by 1H-NMR

    Vedia, JM, Rosales, R, Esteban, Y, Rodriguez-Calvo, R, Plana, N, Ibarretxe, D, Girona, J, Masana, L. 01/08/2023

    Gradual Increase in Inflammation-Linked Glycoproteins and a Proatherogenic Lipoprotein Profile in the Early Stages of Psychosis as Characterized by (1)H NMR Blood Analysis.

    Gallart-Palau X, Muntané G, Martorell L, Amigó N, Correig X, Ribalta J, Sánchez-Gistau V, Labad J, Vilella E. 07/07/2023

    2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.

    Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Hudgins LC, Kayikcioglu M, Masana L, Parhofer KG, Roeters van Lennep JE, Santos RD, Stroes ESG, Watts GF, Wiegman A, Stock JK, Tokgözoglu LS, Catapano AL, Ray KK. 01/07/2023

    Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by (1)HNMR in children with familial hypercholesterolemia.

    Rodríguez-Borjabad C, Narveud I, Christensen JJ, Ibarretxe D, Andreychuk N, Girona J, Torvik K, Folkedal G, Bogsrud MP, Retterstøl K, Plana N, Masana L, Holven KB. 01/05/2023

    Metabolic Overlap between Alzheimer's Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia

    Guardiola, M, Muntané, G, Martínez, I, Martorell, L, Girona, J, Ibarretxe, D, Plana, N, Bullido, MJ, Vilella, E, Ribalta, J. 18/04/2023

    Lipid lowering combination therapy: From prevention to atherosclerosis plaque treatment

    Masana, L, Plana, N, Andreychuk, N, Ibarretxe, D. 01/04/2023

    Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies

    Narváez, J, Estrada, P, Llop, D, Vidal-Montal, P, Brugarolas, E, Maymó-Paituvi, P, Palacios-Olid, J, Nolla, JM. 01/04/2023

    Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus

    Rodríguez-Calvo, R, Granado-Casas, M, de Oca, APM, Julian, MT, Domingo, M, Codina, P, Santiago-Vacas, E, Cediel, G, Julve, J, Rossell, J, Masana, L, Mauricio, D, Lupón, J, Bayes-Genis, A, Alonso, N. 01/03/2023

    PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

    Rehues, P, Girona, J, Guardiola, M, Plana, N, Scicali, R, Piro, S, Muñiz-Grijalvo, O, Díaz-Díaz, JL, Recasens, L, Pinyol, M, Rosales, R, Esteban, Y, Amigó, N, Masana, L, Ibarretxe, D, Ribalta, J. 01/02/2023

    Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype

    Bea, AM, Cenarro, A, Marco-Benedi, V, Laclaustra, M, Martin, C, Ibarretxe, D, Pinto, X, Arrobas, T, Vinals, C, Civeira, F, Olmos, S. 01/02/2023

    Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men

    Zamora, A, Ramos, R, Comas-Cufi, M, García-Gil, M, Martí-Lluch, R, Plana, N, Alves-Cabratosa, L, Ponjoan, A, Rodríguez-Borjabad, C, Ibarretxe, D, Roman-Degano, I, Marrugat, J, Elosua, R, Martín-Urda, A, Masana, L. 27/01/2023

    DDR1 and Its Ligand, Collagen IV, Are Involved in In Vitro Oligodendrocyte Maturation

    Silva, ME, Hernández-Andrade, M, Abasolo, N, Espinoza-Cruells, C, Mansilla, JB, Reyes, CR, Aranda, S, Esteban, Y, Rodriguez-Calvo, R, Martorell, L, Muntane, G, Rivera, FJ, Vilella, E. 01/01/2023

    Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study

    Cordero, A, González-Gallarza, RD, Masana, L, Fuster, V, Castellano, JM, Olivar, JER, Zsolt, I, Sicras-Mainar, A, Juanatey, JRG. 01/01/2023

    Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study

    Masana, L, Zambon, A, Schmitt, CP, Taylan, C, Driemeyer, J, Cohen, H, Buonuomo, PS, Alashwal, A, Al-Dubayee, M, Diaz-Diaz, JL, Maatouk, F, Hervás, SM, Mangal, B, Löwe, S, Cunningham, T. 01/12/2023

    The lockdown of the locked-in: experiences of persons with Locked-in Syndrome during COVID-19 pandemic

    Masana, L, Vidal, F. 03/11/2023

    Triglyceride content increases while cholesterol content decreases in HDL and LDL plus IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals

    Johansen, MO, Moreno-Vedia, J, Balling, M, Smith, GD, Nordestgaard, BG. 01/10/2023

    PCSK9 INHIBITORS HAVE ANTI-INFLAMMATORY ACTIVITY ASSESSED BY 1H-NMR GLYCOPROTEIN PROFILE IN SUBJECTS AT HIGH OR VERY HIGH CARDIOVASCULAR RISK

    Rehues, P, Girona, J, Guardiola, M, Plana, N, Scicali, R, Piro, S, Muñíz-Grijalvo, O, Díaz-Díaz, JL, Recasens, L, Pinyol, M, Rosales, R, Esteban, Y, Amigó, N, Masana, L, Ibarretxe, D, Ribalta, J. 01/08/2023

    AGE EXACERBATES TRIGLYCERIDE-INDUCED HDLC-LOWERING IN WOMEN

    Guardiola, M, Vallvé, J, Rehues, P, Rojo, G, Ribalta, J. 01/08/2023

    Phosphorylation and shedding of DDR1 in the HOG16 human oligodendroglial cell line upon collagen IV incubation

    Castel, SA, Esteban, Y, Rodríquez-Calvo, R, Vilella, E. 01/07/2023

    Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain

    Cosín-Sales, J, Ruiz, RC, Díaz, JLD, Cervantes, CE, Olmo, MRF, Gómez-Doblas, JJ, Mostaza, JM, Pedro-Botet, J, Gili, NP, Valdivielso, P. 01/06/2023

    Glycoprotein and Lipoprotein Profiles Assessed by 1H-NMR and Its Relation to Ascending Aortic Dilatation in Bicuspid Aortic Valve Disease.

    Antequera-González B, Faiges M, Martínez-Micaelo N, Galian-Gay L, Ligero C, Ferré-Vallverdú M, Masana L, Amigó N, Evangelista A, Alegret JM. 31/12/2022

    1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls

    Teis, A, Castelblanco, E, Cediel, G, Amigó, N, Julve, J, Ribalta, J, Guardiola, M, Franch, J, Bermúdez-López, M, Codina, P, Lupón, J, Mauricio, D, Alonso, N, Bayés-Genís, A. 01/11/2022

    The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study

    Gonzalez-Juanatey, JR, Cordero, A, Castellano, JM, Masana, L, Dalmau, R, Ruiz, E, Sicras-Mainar, A, Fuster, V. 15/08/2022

    HUMAN PLASMA GLYCOPROTEIN PROFILE MEASURED BY 1H-NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY IN PATIENTS WITH DIABETES AND/OR ATHEROGENIC DYSLIPIDEMIA, A NEW METHOD TO ASSESS INFLAMMATION

    Amigo, N, Fuertes, R, Malo, A, Plana, N, Ibarretxe, D, Girona, J, Correig, X, Masana, L. 01/08/2022

    CHARACTERIZATION OF THE LPS AND 3OHFA CONTENTS IN THE LIPOPROTEIN FRACTIONS AND LIPOPROTEIN PARTICLES OF HEALTHY SUBJECTS

    Rehues, P, Rodríguez, M, Guardiola, M, Ribalta, J. 01/08/2022

    EFFECTS OF INHIBITOR K-CARRAGEENAN ON HAECS INFLAMMATORY RESPONSE TO LDLS ISOLATED FROM SLE PATIENTS

    Parra, S, Avila, A, Rivalta, J, Guardiola, M, Rodriguez, R, Castro, A. 01/06/2022

    FATIGUE IN RHEUMATOID ARTHRITIS: DOES PATIENT AGE INFLUENCE?

    Rodriguez-Muguruza, S, Castro, S, Poveda, MJ, Paredes, S, Taverner, D, Fontova, R. 01/06/2022

    Muscular carnosine is a marker for cardiorespiratory fitness and cardiometabolic risk factors in men with type 1 diabetes

    Brugnara, L, García, AI, Murillo, S, Ribalta, J, Fernandez, G, Marquez, S, Rodriguez, MA, Vinaixa, M, Amigó, N, Correig, X, Kalko, S, Pomes, J, Novials, A. 01/06/2022

    The Associations Between Sleep Disturbance, Psychological Dysfunction, Pain Intensity, and Pain Interference in Children with Chronic Pain

    Sole, E, Sharma, S, Ferreira-Valente, A, Pathak, A, Sanchez-Rodriguez, E, Jensen, MP, Miro, J. 30/05/2022

    Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

    Vallejo-Vaz, AJ, Bray, S, Villa, G, Brandts, J, Kiru, G, Murphy, J, Banach, M, De Servi, S, Gaita, D, Gouni-Berthold, I, Hovingh, GK, Jozwiak, JJ, Jukema, JW, Kiss, RG, Kownator, S, Iversen, HK, Maher, V, Masana, L, Parkhomenko, A, Peeters, A, Clifford, P, Raslova, K, Siostrzonek, P, Romeo, S, Tousoulis, D, Vlachopoulos, C, Vrablik, M, Catapano, AL, Poulter, NR, Ray, KK. 14/05/2022

    NMR METABOLOMICS, A SUCCESSFUL STRATEGY TO IDENTIFY A TYPE 2 DIABETES MELLITUS (DM) MOLECULAR SIGNATURE BEYOND GLUCOSE IN THE DI@BETES STUDY

    Amigo, N, Ozcariz, E, Rojo, G, Guardiola, M, Ribalta, J. 25/04/2022

    A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting

    Blom, DJ, Gaudet, D, Hegele, RA, Patel, DS, Cegla, J, Kolovou, G, Marin, LM. 01/04/2022

    Combination lipid-lowering therapy as first-line strategy in very high-risk patients.

    Ray KK, Reeskamp LF, Laufs U, Banach M, Mach F, Tokgözoglu LS, Connolly DL, Gerrits AJ, Stroes ESG, Masana L, Kastelein JJP. 22/02/2022

    Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients

    Masana, L, Correig, E, Rodríguez-Borjabad, C, Anoro, E, Arroyo, JA, Jericó, C, Pedragosa, A, la Miret, M, Näf, S, Pardo, A, Perea, V, Pérez-Bernalte, R, Plana, N, Ramírez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. 16/02/2022

    Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national survey

    Guijarro, C, Civeira, F, Lopez-Miranda, J, Masana, L, Pedro-Botet, J, Pinto, X, Valdivielso, P, Mostaza, JM. 01/02/2022

    Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)

    Arrieta, F, Pedro-Botet, J, Iglesias, P, Obaya, JC, Montanez, L, Maldonado, GF, Becerra, A, Navarro, J, Perez, JC, Petrecca, R, Pardo, JL, Ribalta, J, Sánchez-Margalet, V, Duran, S, Tébar, FJ, Aguilar, M. 01/02/2022

    DNA methylation pattern of hypertriglyceridemic subjects

    Guardiola, M, Ibarretxe, D, Plana, N, Masana, L, Ribalta, J. 01/02/2022

    Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects

    Rodríguez, M, Rehues, P, Iranzo, V, Mora, J, Balsells, C, Guardiola, M, Ribalta, J. 16/01/2022

    Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease

    Moreno-Vedia, J, Rosales, R, Ozcariz, E, Llop, D, Lahuerta, M, Benavent, M, Rodriguez-Calvo, R, Plana, N, Pedragosa, A, Masana, L, Castro, A, Ibarretxe, D, Girona, J. 10/01/2022

    Magnetic resonance-assessed lipoprotein profile. The time has come for its clinical use

    Masana, L, Ibarretxe, D. 01/01/2022

    Long-term exposure to PM(10) above WHO guidelines exacerbates COVID-19 severity and mortality.

    Marquès M, Correig E, Ibarretxe D, Anoro E, Antonio Arroyo J, Jericó C, Borrallo RM, Miret M, Perea V, Pérez-Bernalte R, Ramírez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J, Masana L. 01/01/2022

    Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease

    Moreno-Vedia, J, Girona, J, Ibarretxe, D, Masana, L, Rodriguez-Calvo, R. 01/01/2022

    Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men

    Rehues, P, Rodríguez, M, Alvarez, J, Jiménez, M, Melià, A, Sempere, M, Balsells, C, Castillejo, G, Guardiola, M, Castro, A, Ribalta, J. 01/01/2022

    Cross-National Trends of Chronic Back Pain in Adolescents: Results From the HBSC Study, 2001-2014

    Roy, R, Galán, S, Sánchez-Rodríguez, E, Racine, M, Solé, E, Jensen, MP, Miró, J. 01/01/2022

    Nuclear magnetic resonance spectroscopy measure of protein glycosylation is a biomarker of activity and metabolic complications in Inflammatory Bowel Disease

    Mateo, SG, Martínez-Dominguez, SJ, Gonzalvo, MCA, Refaie, E, Llera, BG, Cabrejas, EA, Sanz, B, Grau, NA, Ribalta, J, Martínez-Micaelo, N, Gargallo-Puyuelo, CJ, Gomollón, F. 01/01/2022

    Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL Cholesterol

    Wu, PT, Moon, JY, Daghlas, I, Franco, G, Porneala, BC, Ahmadizar, F, Richardson, TG, Isaksen, JL, Hindy, G, Yao, J, Sitlani, CM, Raffield, LM, Yanek, LR, Feitosa, MF, Cuadrat, RRC, Qi, QB, Ikram, MA, Ellervik, C, Ericson, U, Goodarzi, MO, Brody, JA, Lange, L, Mercader, JM, Vaidya, D, An, P, Schulze, MB, Masana, L, Ghanbari, M, Olesen, MS, Cai, JW, Guo, XQ, Floyd, JS, Jäger, S, Province, MA, Kalyani, RR, Psaty, BM, Orho-Melander, M, Ridker, PM, Kanters, JK, Uitterlinden, A, Smith, GD, Gill, D, Kaplan, RC, Kavousi, M, Raghavan, S, Chasman, DI, Rotter, JI, Meigs, JB, Florez, JC, Dupuis, J, Liu, CT, Merino, J. 01/01/2022

    HTE 3.0: Knowledge-based systems in cascade for familial hypercholesterolemia detection and dyslipidemia treatment

    López, B, Torrent-Fontbona, F, Marín, LM, Zamora, A. 01/01/2022

    SEA 2022 Standards for Global Control of Cardiovascular Risk

    Mostaza, JM, Pinto, X, Armario, P, Masana, L, Real, JT, Valdivielso, P, Arrobas-Velilla, T, Baeza-Trinidad, R, Calmarza, P, Cebollada, J, Civera-Andres, M, Melero, JIC, Diaz-Diaz, JL, Pardo, JF, Guijarro, C, Jerico, C, Laclaustra, M, Lahoz, C, Lopez-Miranda, J, Martinez-Hervas, S, Muniz-Grijalvo, O, Paramo, JA, Pascual, V, Pedro-Botet, J, Perez-Martinez, P, Plana, N, Puzo, J, Chaparro, MAS, Vila, L. 01/05/2022

  • Title: PI21/01294 ' ESTUDIO CLINICO E IN VITRO DE LAS GLICOFORMAS DE APOC-III ASOCIADAS A LIPOPROTEINAS COMO BIOMARCADORES DE DIABETES Y SU ASOCIACION CON EL RIESGO CARDIOVASCULAR EN LA COHORTE PROSPECTIVA DI@BETES ' – PV21115S

    Funding entity: INSTITUTO CARLOS III

    Duration: 2022-2025

    Principal Investigator: RIBALTA VIVES, JOSEP

  • Title: PI22/01974. LIPO Y GLICOPROTEINAS POR RMN EN NIÑOS CON HIPERCOLESTEROLEMIA FAMILIAR. – PV22140S

    Funding entity: INSTITUTO CARLOS III

    Duration: 2023-2026

    Principal Investigator: RODRIGUEZ BORJABAD , CELIA

  • Title: 2021 SGR 00815 GRUP DE RECERCA CONSOLIDAT (GRC) OPICIO FINANÇAMENT COMPETITIU (AVLUACIO CIENTIFICA) URV-IISPV – PV23068S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: RIBALTA VIVES, JOSEP

  • Title: PI24/00909 UN PANEL DE BIOMARCADORES DE LIPOPROTEINAS NO RELACIONADAS CON EL COLESTEROL PARA LA DETECCION TEMPRANA DE LA PROPAGACION RAPIDA DE LA ATEROSCLEROSIS EN SUJETOS CON COLESTEROL LDL NORMAL – PV24127S

    Funding entity: INSTITUTO CARLOS III

    Duration: 2025-2027

    Principal Investigator: RIBALTA VIVES, JOSEP

  • Title: PID2024-162098OB-I00 PROYECTOS GENERACION DEL CONOCIMIENTO_MECANISMOS IMPLICADOS EN LA INHIBICION DE FABP4: ANALISIS DE LAS VIAS TERAPEUTICAS EN LOS TRASTORNOS METABOLICOS RELACIONADOS CON LA OBESIDAD (FIT) – PV25114S

    Funding entity: AGENCIA ESTATAL DE INVESTIGACION

    Duration: 2025-2028

    Principal Investigator: GIRONA TELL, JOSEFA

  • Title: DONACION_ LIPIDOMICA SERICA MEDIANTE 1 H-RMN EN LA DETECCION Y PREVENCION DE LA PREECLAMPSIA: RECLAMA. – PV26054S

    Funding entity: FUNDACION ESPAÑOLA DE ARTERIOESCLEROSIS

    Duration: 2026-2026

    Principal Investigator: IBARRETXE GEREDIAGA , DAIANA

Membres De L’equip